Sugi Predict

Sugi Predict / Compounds / SCHEMBL4015863

SCHEMBL4015863

SCHEMBL4015863

Cc1cc(Nc2cncc(Nc3ccc(C)c(NC(=O)C(C)C)c3)n2)n[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.48
▸ JAK3 P52333 2/20 0.48
▸ AURKA O14965 8/20 0.43
▸ AURKB Q96GD4 7/20 0.40
▸ KDR P35968 1/20 0.39
▸ DHODH Q02127 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ TNIK Q9UKE5 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ RET P07949 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4165669 0.90 MEN1 (0.47) JAK2JAK3AURKAAURKBDHODH
SCHEMBL4169270 0.90 JAK2 (0.46) JAK2JAK3AURKAAURKBKDR
SCHEMBL4013428 0.88 JAK2 (0.44) JAK2JAK3AURKAAURKBKDR
SCHEMBL4169636 0.88 KDR (0.50) JAK2JAK3AURKAAURKBKDR
SCHEMBL4172948 0.88 JAK2 (0.46) JAK2JAK3AURKAAURKBKDR
SCHEMBL4166637 0.86 JAK2 (0.44) JAK2JAK3AURKAAURKBKDR
SCHEMBL4170849 0.86 MEN1 (0.49) JAK2JAK3AURKAAURKBKDR
SCHEMBL4168358 0.85 AURKB (0.43) JAK2JAK3AURKAAURKBKDR
SCHEMBL4021257 0.85 JAK2 (0.43) JAK2JAK3AURKAAURKBKDR
SCHEMBL4165467 0.84 AURKB (0.44) JAK2JAK3AURKAAURKBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US claimed
WO-2009089042-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2009-07-16 — — WO claimed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH MAP3K1, MAP3K15, MAP3K5 JAK2 39/4885JAK3 35/4885AURKA 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.